Gladstone NOW: The Campaign Join Us on the Journey✕
Bruce Conklin, MD, and his team at Gladstone Institutes are tackling Charcot-Marie-Tooth (CMT) disease, the most common inherited neurological disorders—for which there is currently no cure.
Using cells collected from patients with CMT, the scientists are exploring ways to use gene editing as a therapeutic tool to treat the disease.
In this video, Bruce Conklin and Bria Macklin describe their work and explain how it could help patients like Jeremy, an energetic 5-year-old who donated his cells to Gladstone for this research.
Content note: The narration in the first 6 seconds of this video was enhanced using an AI-generated voice.
Gladstone NOW: The Campaign
Join Us On The Journey
In this video, Katie Pollard and Deepak Srivastava explain how Gladstone scientists are combining AI models with novel tools in the lab to finally decode the entire human genome.
Gladstone Experts Pollard Lab Srivastava Lab AIIn this video, Nadia Roan and Ashley George explain how they uncovered a new path toward long-term health without the need for daily HIV pills.
Gladstone Experts Research (Publication) HIV/AIDS Infectious Disease Roan LabFrom fundamental insights to translational advances, here’s how Gladstone researchers moved science forward in 2025.
Gladstone Experts Alzheimer’s Disease Autoimmune Diseases COVID-19 Neurological Disease Genomic Immunology Cardiovascular Disease Data Science and Biotechnology Infectious Disease Conklin Lab